August 25, 2015
Cerenis Therapeutics announces its results for the first half of 2015.
Media
August 20, 2015
Nordic Nanovector ASA to present at Pareto Securities’ 6th Annual Health Care Seminar
August 11, 2015
Key Technology Patent Granted for US
August 11, 2015
U.S. FDA Approves ZUBSOLV® for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence
August 10, 2015
BioClin Therapeutics Initiates Phase 2 Clinical Trial Evaluating B-701 for Treatment of Urothelial Cell Carcinoma
August 04, 2015
ZUBSOLV® Market Access Update on Agreement with CVS Caremark and Announcement of New Exclusive Agreement in Managed Medicaid
August 03, 2015
Cortendo Announces Plans to Redomicile the Cortendo Group’s Parent Company from Sweden to Ireland By Means of an Exchange Offer
July 28, 2015
Q2 2015 General Market Overview
July 27, 2015
Vaxin First-in-Man Phase I Clinical Trial Initiated in Chronically Infected Hepatitis B Patients
July 23, 2015
GenSight Biologics Closes $36 Million Series B Preferred Stock Financing